Verdence Capital Advisors LLC Astrazeneca PLC Transaction History

Verdence Capital Advisors LLC

$1.28 Billion
Q1 2025

A detailed history of Verdence Capital Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Verdence Capital Advisors LLC holds 39,301 shares of AZN stock, worth $2.83 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

39,301

Previous 32,508 20.9%

Holding current value

$2.83 Million

Previous $2.13 Million 35.65%

% of portfolio

0.23%

Previous 0.18%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 02, 2025	BUY	$65.37 - $77.96 $444,058 - $529,582	6,793 Added 20.9%	39,301 $2.89 Million
Q4 2024 Feb 06, 2025	BUY	$63.2 - $79.58 $190,042 - $239,297	3,007 Added 10.19%	32,508 $2.13 Million
Q3 2024 Nov 01, 2024	BUY	$76.67 - $87.62 $154,873 - $176,992	2,020 Added 7.35%	29,501 $2.3 Million
Q2 2024 Jul 25, 2024	BUY	$66.81 - $80.83 $677,252 - $819,373	10,137 Added 58.45%	27,481 $2.14 Million
Q1 2024 Apr 25, 2024	BUY	$61.03 - $69.57 $53,218 - $60,665	872 Added 5.29%	17,344 $1.18 Million
Q4 2023 Jan 31, 2024	SELL	$61.89 - $69.28 $67,955 - $76,069	-1,098 Reduced 6.25%	16,472 $1.11 Million
Q3 2023 Oct 25, 2023	BUY	$64.85 - $71.7 $70,038 - $77,436	1,080 Added 6.55%	17,570 $1.19 Million
Q2 2023 Jul 28, 2023	SELL	$69.91 - $75.81 $142,127 - $154,121	-2,033 Reduced 10.98%	16,490 $1.18 Million
Q1 2023 Apr 24, 2023	SELL	$63.15 - $71.6 $12,251 - $13,890	-194 Reduced 1.04%	18,523 $1.29 Million
Q4 2022 Jan 20, 2023	BUY	$54.21 - $70.44 $69,443 - $90,233	1,281 Added 7.35%	18,717 $0
Q3 2022 Nov 15, 2022	BUY	$53.02 - $135.75 $40,136 - $102,762	757 Added 4.54%	17,436 $956,000
Q2 2022 Aug 08, 2022	BUY	$59.26 - $71.14 $165,690 - $198,907	2,796 Added 20.14%	16,679 $1.1 Million
Q1 2022 May 02, 2022	BUY	$55.72 - $67.12 $5,906 - $7,114	106 Added 0.77%	13,883 $921,000
Q4 2021 Jan 26, 2022	BUY	$54.02 - $63.83 $86,972 - $102,766	1,610 Added 13.23%	13,777 $803,000
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $101,674 - $111,245	1,830 Added 17.7%	12,167 $731,000
Q2 2021 Aug 06, 2021	SELL	$48.42 - $60.18 $3,583 - $4,453	-74 Reduced 0.71%	10,337 $619,000
Q1 2021 May 11, 2021	BUY	$47.16 - $54.44 $201,561 - $232,676	4,274 Added 69.64%	10,411 $518,000
Q4 2020 Feb 12, 2021	BUY	$48.52 - $58.02 $297,767 - $356,068	6,137 New	6,137 $307,000
Q1 2019 Mar 02, 2020	SELL	$35.49 - $43.02 $523,938 - $635,104	-14,763 Closed	0 $0
Q4 2018 Feb 25, 2020	SELL	$36.86 - $41.49 $166,164 - $187,036	-4,508 Reduced 23.39%	14,763 $561,000
Q3 2018 Feb 25, 2020	SELL	$34.76 - $39.72 $456,537 - $521,682	-13,134 Reduced 40.53%	19,271 $763,000
Q2 2018 Feb 11, 2020	SELL	$34.55 - $37.05 $155,198 - $166,428	-4,492 Reduced 12.17%	32,405 $1.14 Million
Q1 2018 Jan 30, 2020	SELL	$32.97 - $36.63 $57,664 - $64,065	-1,749 Reduced 4.53%	36,897 $1.29 Million
Q4 2017 Jan 30, 2020	BUY	$32.09 - $34.78 $1.24 Million - $1.34 Million	38,646	38,646 $1.34 Million

Others Institutions Holding AZN

# of Institutions

1,389

Shares Held

473M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $223B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verdence Capital Advisors LLC with notifications on news.

Account

Verdence Capital Advisors LLC Astrazeneca PLC Transaction History